Background: Automated and convenient multianalyte detection with high throughput is increasingly needed in clinical diagnosis. We developed a disposable 4-by-2 array for programmed simultaneous amperometric immunoassay of 4 tumor markers. Methods: We used a screen-printed technique, 1-step immobilization method, and flow injection technique. We immobilized carcinoembryonic antigen, ␣-fetoprotein, ␤-human choriogonadotropin, and carcinoma antigen 125 as model analytes in a redox mediator-grafted, biopolymer-modified, screen-printed carbon electrode array to capture corresponding horseradish peroxidaselabeled antibodies in competitive immunoreactions. The simultaneous multianalyte immunoassay was automatically carried out to amperometrically monitor the mediator-catalyzed enzymatic response to hydrogen peroxide, which decreased in proportion to the concentrations of analytes in samples. 
Recently, immunosensors and immunoassay methods for single-tumor markers have been well developed for cancer screening (1, 2 ) . Their applications are facing great challenges, because most markers are not specific to a particular tumor. Panels of tumor markers can improve their diagnostic value (3) (4) (5) . Thus a simultaneous multianalyte immunoassay with short analytical time, high throughput, small sampling volume, and low cost possesses considerable importance for cancer screening (6, 7 ) .
Various approaches have been proposed to perform simultaneous multianalyte immunoassays (8 -12 ) , including label-free and labeled probe methods (13 ) . Label-free immunoassays are difficult to develop because of the lack of a detectable protein signal or a signal too weak to quantify the trace amount of analytes (14 ) . Labeled probe methods such as multilabel and spatially resolved assays can offer amplified detection signals for multianalyte immunoassays. Multilabel methods need several labels, such as radioisotopes (15 ) , fluorescence dyes (16 ) , enzymes (17, 18 ) , metal ions (12, 14, 19 ) , or quantum dots (20, 21 ) , which limits their application. Spatially resolved array assays with a single label can perform simultaneous detection of analytes by both optical (22) (23) (24) and electrochemical (25 ) responses. Although the optical multianalyte immunoassay has been well developed, electrochemical arrays have the advantage of not needing a sophisticated and expensive array detector, and thus show promise (7, 26 ) .
The electrochemical immunoassay has the advantages of low detection limit, small analyte volume, simple instrumentation, and minimal manipulation, and the assay system can easily be miniaturized (27, 28 ) . Many attempts have been made toward the development of electrochemical array-sensors focusing on immobilizing receptors at sensitive transducers, minimizing cross-talk, and maximizing performance. By immobilizing capture antibodies in siloxane layers to retard the diffusion of enzyme-generated product, a protein microchip has been proposed (29 ) . Wilson and colleagues (7, 25, 26 ) reported a series of electrochemical arrays by covalently binding or physically adsorbing analytes on iridium oxide electrodes to recognize alkaline phosphatase-labeled antibodies. They avoided electrochemical cross-talk by making the distance between adjacent electrodes larger than the diffusion distance of the enzymatic product; this, however, was disadvantageous to the further miniaturization of the electrochemical sensor array.
Chitosan (CHIT) 3 , a kind of natural biopolymer, has been widely used as an immobilization matrix because of its excellent film-forming ability, high permeability toward water, good adhesion, biocompatibility, nontoxicity, and high mechanical strength (30 ) . Recently, it has been increasingly used for biofabrication because of the presence of reactive amino and hydroxyl functional groups (31 ) . CHIT grafted with mediators has also been shown to have attractive properties of enzyme immobilization and activity maintenance (32) (33) (34) (35) . For these reasons, we used grafted CHIT in the present studies. Our goal was to develop a simple and low-cost method for diagnosis of cancer with a combination of multitumor markers.
Materials and Methods overview
We used grated CHIT to immobilize 4 tumor markers at screen-printed carbon electrodes (SPCE) for preparation of a novel immunosensor array. The redox mediator, toluidine blue O (TBO) to CHIT using glutaric dialdehyde (GDI) as a molecular tether (35 ) , accelerated the electrochemical reduction of hydrogen peroxide catalyzed by horseradish peroxidase (HRP)-labeled monoclonal antibodies; this increased the sensitivity of the immunoassay. The immobilized TBO and the captured HRP-labeled antibodies avoided cross-talk between immunosensors.
apparatus
The disposable immunosensor array was connected to a flow injection system as illustrated in Fig. 1 . Briefly, this system comprised 2 peristaltic pumps (Baoding Longer Precision Pump Co.), an 8-port rotary injection valve, and a homemade flow cell, which were connected using polytetrafluorethylene tubes (0.8 mm internal diameter). We performed electrochemical measurements on a 4-channel potentiostat (eDAQ Co.) equipped with an e-corder system. We used an electronic switch coupled with the potentiostat for simultaneous 8-analyte detection of 2 groups of a 6-electrode system. We obtained scanning electron micrographs with a JSM-5610LV scanning electron microscope (JEOL), infrared spectra with a VECTOR 22 spectrometer by preparing the samples on KBr tablets, and UV-Vis spectra with a Shimadzu UV-3600 UV-Vis Spectrophotometer. We detected control levels of the tumor markers in sera with an automated electrochemiluminescence (ECL) analyzer (Elecsys 2010; Roche).
reagents
We purchased carcinoembryonic antigen (CEA), ␣-fetoprotein (␣-AFP), and carcinoma antigen 125 (CA 125) ELISA reagent sets from CanAg Diagnostics. They consisted of a series of CEA, ␣-AFP, and CA 125 solutions with concentrations from 0 to 75 g/L, 0 to 500 g/L, and 0 to 500 kIU/L, respectively, and the stock solutions of HRP-labeled CEA, ␣-AFP, and CA125 monoclonal antibodies. The ␤-human choriogonadotropin (␤-hCG) ELISA reagent set (Biocell Biotechnology) consisted of a series of ␤-hCG solutions from 0 to 400 IU/L and a stock solution of HRP-labeled ␤-hCG monoclonal antibody. We purchased BSA, CHIT (molecular weight ϳ1 ϫ 10 6 Da; ϳ85% deacetylation), and TBO from Sigma-Aldrich Chemical. All other reagents were of analytical reagent grade and used without further purification. We used 0.1 mol/L Tris-HCl (pH 7.2) containing 10 g/L BSA as blocking buffer and dilution solution of the enzyme conjugates. We prepared 0.2 mol/L PBS of various pHs by mixing the 
synthesis of tbo-grafted chit biopolymer
The covalent attachment of TBO molecules to CHIT biopolymer relied on the formation of Schiff bases by reacting amino groups of TBO and CHIT with GDI (35 ) . First, we prepared CHIT stock solution (10 g/L) by ultrasonically dissolving CHIT powder in 1% acetic acid and adjusting the pH to 5.0. We mixed the CHIT solution with an excess of GDI and allowed them to react for 48 h with constant stirring at room temperature. A high molar ratio of GDI to CHIT glucosamine units (200:1) was adopted to ensure that only 1 aldehyde group of GDI reacted with the amino groups of CHIT. The free GDI was removed from the mixture by dialyzing it against 1% acetic acid, which was monitored by UV-Vis spectrophotometry. Next, the CHIT-GDI solution was reacted with an excess of TBO for 48 h with constant stirring at room temperature. Again, dialysis was used to remove free TBO from the mixture. Finally, the Schiff bases in the product were reduced to more stable secondary amines using sodium cyanoborohydride to obtain the CHIT-TBO solution with a concentration corresponding to 1 g/L CHIT. We removed the remaining sodium cyanoborohydride and its oxidized product from the formed films by simple washing.
fabrication of immunosensor array
Construction of the multianalyte immunosensor array is shown in Fig. 1A . It contained 8 (4-by-2) graphite working electrodes (2 mm diameter, 0.5 mm edge-to-edge separation), 1 graphite auxiliary electrode, and 1 Ag/AgCl reference electrode. All working electrodes shared the same reference and auxiliary electrodes. We fabricated the 10-electrode array according to a previous report (36 ) . The insulating layer printed around the working area constituted a reservoir of the electrochemical microcell.
CEA (75 g/L), ␣-AFP (500 g/L), CA 125 (500 kIU/ L), and ␤-hCG (400 IU/L) were mixed with the CHIT-TBO solution at the same volume ratio of 1:3. After the mixtures were placed at 4°C for 12 h, 1 L of each was individually dropped on the working electrodes (Fig. 1) . After drying at room temperature for 2-3 h, the formed films were incubated with blocking buffer for 30 min to block the sites against nonspecific adsorption and thoroughly rinsed with water to obtain a multianalyte immunosensor array, which was stored in air before use.
assay protocol
The simultaneous multianalyte immunoassay included an incubation step, in which the antigens immobilized on working electrodes and the antigens in sample solution competitively bound a limited amount of HRP-labeled antibodies, and an automated detection step to amperometrically monitor the enzymatic reduction of H 2 O 2 by the labeled HRP in the presence of the immobilized TBO as mediator to shuttle electrons between the HRP and the electrodes (Fig. 1) . The 40-min incubation step could be performed in batches with different immunosensor arrays, using the mixture solutions of diluted HRP-labeled anti-CEA, anti-␣-AFP, anti-CA 125, and anti-␤-hCG and samples or CEA, ␣-AFP, CA 125, and ␤-hCG solutions at room temperature and 100% relative humidity to avoid evaporation of solvent. After the residual was removed with water, the arrays were sequentially fixed in the flow system with deoxygenated 0.2 mol/L PBS (pH 6.5) as carrier at a flow rate of 3.6 mL/min. We then applied Ϫ0
Results and Discussion characterization of chit-tbo
We verified the grafting of CHIT with TBO molecules with infrared spectra (see Fig. 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol53/issue8). The CHIT showed a strong adsorption of -NH 3 ϩ deformation around 1572 cm Ϫ1 (37 ) , which covered the characteristic absorption of amide I (CϭO in OϭC-NH) and amide II (-NH in OϭC-NH) of CHIT at pH 5.0 (38 ). Although we observed a very weak absorption of OϭC-at 1714 cm Ϫ1 , it was greatly strengthened after the reaction of CHIT with GDI, indicating the presence of -CHO group in CHIT-GDI. Thus the GDI molecules were attached to CHIT with 1 end. This reaction greatly decreased the adsorption of -NH 3 ϩ deformation, and we observed a weak adsorption peak for amide I (CϭO in OϭC-NH) of CHIT at 1640 cm Ϫ1 . After grafting of CHIT with TBO molecules and reduction of the formed Schiff bases, the peak at 1714 cm Ϫ1 decreased again, and we observed the same strength as that for CHIT. At the same time, we observed the adsorption ascribed to the TBO unit at 1640 cm Ϫ1 , indicating the formation of CHIT-TBO. The grafting of TBO molecules to CHIT matrix could further be supported by UV-Vis spectra (see Fig. 2 in the online Data Supplement). The UV-Vis spectrum of CHIT-TBO solution displayed the absorption band of free TBO with a peak at 625 nm, which did not occur on the UV-Vis spectra of CHIT or CHIT-GDI solutions.
The formed CHIT-TBO film showed an even surface, which made up the surface defects of bare SPCE (see Fig.  3 in the online Data Supplement) and greatly improved the repeatability for electrochemical measurement. After Clinical Chemistry 53, No. 8, 2007 antigen molecules were entrapped in the grafted biopolymer, the resulting modified SPCE showed a uniform porous structure. Thus the HRP-labeled antibody molecules could be easily accessible to the immobilized antigen molecules to form immunocomplexes.
optimization of detection system
We performed the simultaneous multianalyte immunoassay of 4 tumor markers with a flow injection system at an optimized applied potential of Ϫ0.5 V (see Fig. 4 in the online Data Supplement). The flow rate of the carrier solution should be considered: high flow rates would produce unstable detection signals, whereas detection signals suffer from tailing at a slow flow rates. Here, we used a flow rate of 3.6 mL/min for the simultaneous multianalyte immunoassay, at which only the concentration of H 2 O 2 and the pH of the detection solution affected the amperometric response. Fig. 2 shows their effect on the responses of the immunosensor array.
With the increasing concentration of H 2 O 2 , all immunosensors for the 4 tumor markers showed increasing responses, which reached maximum values at the H 2 O 2 concentration of 10.7 mmol/L. The enzymatic reaction depended on the solution pH, and the effects of pH on the responses of these immunosensors also showed the same tendency due to the same response mechanism. The maximum responses occurred around pH 6.5. Thus, we used pH 6.5 PBS with an injection of 10.7 mmol/L H 2 O 2 for the simultaneous multianalyte immunoassay.
optimization of immunoreactions
Under optimal detection conditions, the amperometric responses of the immunosensor array depended on the formation of immunocomplexes, which was related to the incubation temperature, incubation time, and working concentration of HRP-labeled antibodies. For convenient manipulation, the incubation step was performed at room temperature, at which the amperometric responses increased with the increasing incubation time and trended to the constant values at 40 min, except that for CEA at 30 min (Fig. 3, A and B) , indicating a saturated binding between the immobilized antigens and HRP-labeled antibodies. Thus we chose 40 min as the optimal incubation time for the simultaneous multianalyte immunoassay.
The amount of HRP-labeled antibodies in the incubation solution was a key in the competitive immunoassay format. The effects of dilutions of HRP-labeled antibodies in the incubation solution on the amperometric responses are shown in Fig. 3, C 
evaluation of cross-reactivity and cross-talk behavior
An excellent immunosensor array must exclude crossreactivity between analytes and noncognate antibodies and cross-talk between neighboring electrodes (26 ). We examined cross-reactivity between the tumor marker and other 3 noncorresponding antibodies using cyclic voltammetry and incubation in the solution containing 1 HRPlabeled antibody. Although all immunosensors showed the electrocatalytic response to the reduction of H 2 O 2 catalyzed by the HRP, only the immunosensor incubated with its corresponding HRP-labeled antibody solution showed the electrocatalytic response (see Fig. 4 in the online Data Supplement). Thus the cross-reactivity and nonspecific binding were negligible, suggesting that the 4 tumor markers could be assayed individually in a single run without interference.
Generally, electrochemical cross-talk in the sensor array results from the diffusion of electroactive product of the enzymatic reaction on 1 electrode to neighboring electrodes. To our best knowledge, its elimination mainly focuses on making sure the distance between adjacent electrodes is larger than the diffusion distance of enzymatic product (7, 25, 26, 29 ) . In this work, the electrontransfer mediator TBO was covalently immobilized on the immunosensor surfaces during the fabrication of the immunosensor array instead of in the detection solution; no diffusion of electroactive product occurred, and the electrochemical cross-talk between the electrodes could be completely avoided. It was unnecessary to consider the separate distance between neighboring electrodes, enhancing further miniaturization of the array. Using CEA immunosensor as an example, the results are shown in Fig. 4 . After an array containing both CEA immunosensor and CHIT-TBO film-modified electrode was incubated in a diluted HRP-labeled antibody solution, upon injection of H 2 O 2 the modified electrode showed a very small response from the direct reduction of H 2 O 2 at Ϫ0.5 V, whereas the CEA immunosensor produced a prominent amperometric response due to the enzymatic reaction (Fig. 4, curve b vs a) . The response of the CEA immunosensor in a multichannel format was the same as in a single-channel format (Fig. 4, curve a vs c) .
sample throughput and assay performance
The amperometric response of H 2 O 2 at the array showed a half-width of 4 s with a base-width of 15 s (Fig. 4) . Thus the simultaneous multianalyte detection of 4 tumor markers using 1 array could be accomplished within 60 s, containing a period of 15 s for the fixing of the incubated Fig. 6 , compared with those obtained using the commercial ECL single-analyte testing. The commercial ECL assay showed that all ␤-hCG concentrations in these samples were lower than the threshold value, whereas our proposed method showed 5 samples that gave slightly higher results than those obtained from the commercial assay, indicating acceptable reliability for ␤-hCG. The commercial testing of ␣-AFP showed that 28 of 34 samples were clinically negative and 6 samples were clinically positive, of which 4 samples showed concentrations Ͼ2000 g/L beyond the linear detection range of the proposed method. Fig. 6B 6, C and D) . Both the good correlation coefficients and the slopes close to 1 indicated acceptable accuracy of this proposed method.
repeatability, reproducibility, and stability of the array
We evaluated the interassay imprecision of the immunosensor arrays at different concentrations of the 4 tumor markers using 5 arrays. The CVs were 4.3% and 3.2% for 10.2 and 17.6 g/L CEA, 3.4% and 4.2% for 4.9 and 22.1 g/L ␣-AFP, 7.8% and 4.3% for 6.6 and 29.4 kIU/L CA 125, and 5.5% and 7.2% for 4.9 and 23.5 IU/L ␤-hCG, indicating acceptable imprecision and fabrication reproducibility. The intraassay CVs of this method examined with 5 injections of H 2 O 2 at 1 array were Ͻ2.2%, 5.4%, 9.0%, and 3.7% for CEA, ␣-AFP, CA 125, and ␤-hCG, respectively, showing acceptable repeatability. When the immunosensor array was stored in air at room temperature, it could keep the initial responses of these immunosensors for 28 days. After a storage period of 40 days, the amperometric responses of the CEA, ␣-AFP, CA 125, and ␤-hCG immunosensors were 85.7%, 92.3%, 93.7%, and 85.5% of their initial responses, respectively. Thus the immunosensor array had acceptable storage stability and is suitable for clinical diagnosis.
In conclusion, the proposed automated method coupled with the immunosensor arrays is simple, convenient, rapid, high-throughput, and low-cost. For widening the linear ranges of the simultaneous multianalyte detection further, work based on a sandwich format is going on in this laboratory. 
